Headlines

MID WEB AD_Vertical left side 426 pixels (height) x 170 pixels (width).gif

MBS is associated with greater long-term heart risk reduction than GLP-1 medications

Both metabolic and bariatric surgery (MBS) and glucagon-like peptide-1 receptor agonist (GLP-1RA) medications improve cardiovascular health in people with obesity, but surgery was associated with significantly greater reductions in long-term cardiovascular risk, according to a study by researchers from the Mayo Clinic. Importantly, researchers say the findings are not about choosing one treatment over another, but about better aligning treatment decisions with long-term healt

MBS is associated with greater long-term heart risk reduction than GLP-1 medications

Looking forward to Malaga and IFSO-EC 2026

French researchers highlight more complex and potentially more morbid types of revisional bariatric surgeries

Research

FitForMe launches new supplements addressing protein deficiency, digestive issues and nutritional deficiencies during obesity treatment

More than one billion people worldwide are living with obesity. Lifestyle intervention programmes, GLP-1 medications and bariatric surgery can be transformative, but they do not exist in a nutritional vacuum. Deficiencies are common among people affected by obesity before treatment begins, and surgery or medication can make them harder to ignore. Patients arrive underprepared, find little nutritional support built into their care, and are largely left to manage the consequenc

MBS is associated with greater long-term heart risk reduction than GLP-1 medications

Inconsistent use of GLP-1s may make the drug less effective

Inconsistent use of some GLP-1 weight-loss medications, like Ozempic and Wegovy, may significantly lessen their effectiveness, according to a preclinical study from researchers at the Perelman School of Medicine at the University of Pennsylvania. The study showed that each time overweight mice stopped and restarted GLP-1s, they dropped less and less weight compared their original weight-loss. “The effectiveness of these medications may depend heavily on consistency,” said Dr

Olympus gains FDA clearance for POWERSEAL Open Extended Jaw Device

Olympus Corporation has received FDA 510(k) clearance for the POWERSEAL Open Extended Jaw Sealer/Divider. This latest edition to the Olympus POWERSEAL advanced bipolar surgical energy portfolio supports clinical needs for precision, efficiency and control during surgery. POWERSEAL Open Extended Jaw Sealer/Divider The POWERSEAL Open Extended Jaw Sealer/Divider joins three 5mm devices in the POWERSEAL portfolio. These 5mm devices are offered in three jaw configurations, each av

Obesity leaves a lasting memory in immune cells

People who live with obesity are "tagging" a memory of being overweight on a key part of the immune system - leaving people with ongoing risk of obesity-related conditions years after losing weight, according to a 10-year-long study led by University of Birmingham, UK. A European research team led by Professor Claudio Mauro from the University of Birmingham has shown that immune cells known as helper T cells (or CD4+ lymphocytes) carry a long memory of obesity. "The findings

Ascletis completes enrolment in US Phase II Study of ASC30

Ascletis Pharma has completed enrolment in its 13-week US Phase II study evaluating ASC30, an oral small molecule GLP-1 receptor (GLP-1R) agonist, for the treatment of type 2 diabetes mellitus (T2D). T2D is the second indication for ASC30, following its first indication of obesity. Topline data from the Phase II study for the treatment of T2D are expected in the third quarter of 2026. The Phase II study is a 13-week, randomised, double-blind, placebo-controlled and multi-cent

Concomitant laparoscopic cholecystectomy during bariatric surgery is safe and feasible

A prospective randomised controlled pilot study by researchers from Mansoura University, Mansoura, Egypt, has demonstrated that concomitant laparoscopic cholecystectomy (LC) during bariatric surgery in patients with morbidly obesity with pre-existing gallstones is safe and feasible. Although concomitant LC results in longer operative time (mean increase of 23.75 min) and higher immediate postoperative pain scores, the researchers noted that these differences do not translate

J&J gains CE Mark Approval for ETHICON 4000 Stapler

Johnson & Johnson has received European CE Mark approval for its new ETHICON 4000 Stapler, an advanced surgical stapler designed to deliver reliable staple line integrity across a wide range of tissue thickness. ETHICON 4000 Stapler With proprietary 3D Stapling Technology, a redesigned end-effector and streamlined reload options, the ETHICON 4000 and ETHICON 3D Reloads are certified for use in open and laparoscopic surgery across the European Union. The new advanced stapling

Improving patient compliance in multivitamin supplementation

Compliance with any multivitamin and/or protein supplement regimen can be difficult, especially after bariatric surgery. Nutritional deficiency, as a result of gastric bypass surgery, is a substantial possibility without any form of supplementation and even with compliance to standard multivitamin supplementation.1 Problematic adherence The multivitamin supplementation (MVS) regimen could have a major impact on patient adherence,

Stigma toward women who lose weight using GLP-1 medications is greater compared to weight loss via diet and exercise

Women who lost weight using GLP-1 medications are judged more harshly than those who lost weight through diet and exercise, with negative reactions driven largely by beliefs that medication-assisted weight loss is a ‘shortcut’, according to a study by Georgetown University Medical Center researchers. The study also found higher levels of stigma when the women in sample scenarios were portrayed as white rather than Black. The findings highlight how social narratives about ‘acc

Looking forward to Malaga and IFSO-EC 2026

In this exclusive interview, Professor Luis Ocaña (Hospital Universitario Virgen de la Victoria de Málaga, Spain), IFSO-EC Malaga 2026 Congress President, discusses some of the key highlights at this year’s meeting with a particular focus on the Pre-Congress Courses, the importance medication and surgery, collaboration with SECO (Spanish Society of Bariatric Surgery) and, of course, the sights and sounds of the beautiful city of Malaga... “We have been working with huge enthu

Reach Surgical gains CE Mark for iREACH IRIS, the first powered reusable stapler with Real-Time Firing Curve and 90° Articulation

Reach Surgical, the surgical solutions division of Genesis MedTech, has received CE Mark approval for iREACH IRIS, a next-generation powered stapling platform designed to deliver Real-Time Firing Curve and up to 90° articulation during surgery. iREACH IRIS Reusable Stapler with Real-Time Firing Curve™ and 90° Articulation Unlike conventional powered staplers that provide general firing feedback, iREACH IRIS Real-Time Firing Curve provides a continuous, location-specific force

Industry

FitForMe launches new supplements addressing protein deficiency, digestive issues and nutritional deficiencies during obesity treatment

Olympus gains FDA clearance for POWERSEAL Open Extended Jaw Device

J&J gains CE Mark Approval for ETHICON 4000 Stapler

Reach Surgical gains CE Mark for iREACH IRIS, the first powered reusable stapler with Real-Time Firing Curve and 90° Articulation

All caught up?

See all news

New: Directory

Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.

Browse directory

Events

14th Congress of the European Chapter of the International Federation for the Surgery and Other Therapies For Obesity

View details

26 June 2026

4th Annual International Symposium on Magnetic Gastrointestinal & Colon Surgery

View details

1 September 2026

XXIX IFSO World Congress

View details

27 November 2025

6th London International Bariatric Surgery Symposium (LIBSS)

View details

Headlines

MBS is associated with greater long-term heart risk reduction than GLP-1 medications

MBS is associated with greater long-term heart risk reduction than GLP-1 medications

MBS is associated with greater long-term heart risk reduction than GLP-1 medications

Looking forward to Malaga and IFSO-EC 2026

French researchers highlight more complex and potentially more morbid types of revisional bariatric surgeries

Research

FitForMe launches new supplements addressing protein deficiency, digestive issues and nutritional deficiencies during obesity treatment

MBS is associated with greater long-term heart risk reduction than GLP-1 medications

Inconsistent use of GLP-1s may make the drug less effective

Olympus gains FDA clearance for POWERSEAL Open Extended Jaw Device

Obesity leaves a lasting memory in immune cells

Ascletis completes enrolment in US Phase II Study of ASC30

Concomitant laparoscopic cholecystectomy during bariatric surgery is safe and feasible

J&J gains CE Mark Approval for ETHICON 4000 Stapler

Improving patient compliance in multivitamin supplementation

Stigma toward women who lose weight using GLP-1 medications is greater compared to weight loss via diet and exercise

Looking forward to Malaga and IFSO-EC 2026

Reach Surgical gains CE Mark for iREACH IRIS, the first powered reusable stapler with Real-Time Firing Curve and 90° Articulation

Industry

FitForMe launches new supplements addressing protein deficiency, digestive issues and nutritional deficiencies during obesity treatment

Olympus gains FDA clearance for POWERSEAL Open Extended Jaw Device

J&J gains CE Mark Approval for ETHICON 4000 Stapler

Reach Surgical gains CE Mark for iREACH IRIS, the first powered reusable stapler with Real-Time Firing Curve and 90° Articulation

All caught up?

New: Directory

Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.

Events

(See all)

London International Robotic Surgery Conference

4th IFSO MENAC Meeting

BOMSS ASM 2026

6th LIBSS

2026 IBC University of Oxford World Congress

14th Congress of the European Chapter of the International Federation for the Surgery and Other Therapies For Obesity

4th Annual International Symposium on Magnetic Gastrointestinal & Colon Surgery

XXIX IFSO World Congress

6th London International Bariatric Surgery Symposium (LIBSS)

Tweets

Back to Top